NOTCH1 and metabolic dysfunction-associated steatohepatitis: Specifically, ginsenoside Rg5 inhibits the activation of the Notch1 signaling pathway by upregulating the expression of Sirt1 protein, thereby suppressing hepatic lipid accumulation and fibrosis in non-alcoholic steatohepatitis (NASH).